NCT04955743 2025-11-24Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell CarcinomaYale UniversityPhase 2 Terminated18 enrolled
NCT05263492 2025-10-02Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial CancerVirginia Commonwealth UniversityPhase 2 Terminated4 enrolled 8 charts
NCT04729348 2025-07-25Pembrolizumab And Lenvatinib In Leptomeningeal MetastasesMassachusetts General HospitalPhase 2 Terminated10 enrolled